Prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast cancer

Billy Bennett

We investigated the prognostic influences of BCL1 and BCL2 expression on disease-free survival in breast most cancers sufferers. BCL1 and BCL2 expression statuses had been assessed by immunohistochemistry utilizing tissue microarrays from 393 breast most cancers sufferers. The Kaplan-Meier estimator and log-rank check had been used for survival analyses. The Cox proportional hazards mannequin was used to calculate hazard ratio (HR) and the 95% confidence interval (CI) of survival analyses. BCL1 expression revealed no affect on survival. The excessive BCL2 group confirmed superior disease-free survival in contrast with the low BCL2 group (p = 0.002), particularly concerning native recurrence-free survival (p = 0.045) and systemic recurrence-free survival (p = 0.002).

BCL2 expression was a big prognostic issue by univariable evaluation (HR, 0.528; 95% CI, 0.353-0.790; p = 0.002) and by multivariable evaluation (HR, 0.547; 95% CI, 0.362-0.826; p = 0.004). Excessive BCL2 expression was related to greater disease-free survival within the hormone receptor (HRc)-positive and human epidermal progress issue receptor 2 (HER2)-negative (HRc(+)/HER2(-)) subtype solely (p = 0.002). The excessive BCL2 group was related to optimistic estrogen receptor (ER), optimistic progesterone receptor (PR), low histologic grade, and age ≤ 50 years.

BCL1 expression had no prognostic affect, however BCL2 expression was a big unbiased prognostic issue. Excessive BCL2 expression was related to greater disease-free survival, particularly concerning native recurrence and systemic recurrence. The prognostic impact of BCL2 expression was efficient solely within the HRc(+)/HER2(-) subtype. Favorable clinicopathologic options and a robust affiliation with the ER/PR standing might partly clarify the superior prognosis of the excessive BCL2 group. BCL2 expression could possibly be utilized to evaluate the prognosis of breast most cancers sufferers in scientific settings.

Predicting ROR1/BCL2 mixture focused remedy of small cell carcinoma of the lung

Small cell lung most cancers (SCLC) stays a lethal type of most cancers, with a 5-year survival fee of lower than 10 %, necessitating novel therapies. Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is an oncofetal protein that’s rising as a therapeutic goal and is co-expressed with BCL2 in a number of tumor varieties as a result of microRNA coregulation. We hypothesize that ROR1-targeted remedy is efficient in small cell lung most cancers and synergizes with therapeutic BCL2 inhibition.

Tissue microarrays (TMAs) and formalin-fixed paraffin-embedded (FFPE) SCLC affected person samples had been utilized to find out the prevalence of ROR1 and BCL2 expression in SCLC. Eight SCLC-derived cell strains had been used to find out the antitumor exercise of a small molecule ROR1 inhibitor (KAN0441571C) alone and together with the BCL2 inhibitor venetoclax.
The Chou-Talalay technique was utilized to find out synergy with the drug mixture. ROR1 and BCL2 protein expression was recognized in 93% (52/56) and 86% (48/56) of SCLC affected person samples, respectively. Equally, ROR1 and BCL2 had been proven by qRT-PCR to have elevated expression in 79% (22/28) and 100% (28/28) of SCLC affected person samples, respectively. KAN0441571C displayed efficacy in eight SCLC cell strains, with an IC50 of 500 nM or much less.
Synergy as outlined by a mixture index of <1 through the Chou-Talalay technique between KAN0441571C and venetoclax was demonstrated in eight SCLC cell strains. Now we have proven that ROR1 inhibition is synergistic with BCL2 inhibition in SCLC fashions and reveals promise as a novel therapeutic goal in SCLC.

Expression and Practical Evaluation of the BCL2-Related Agonist of Cell Dying (BAD) Gene in Grass Carp (Ctenopharyngodon idella) Throughout Bacterial An infection

The BCL2-associated agonist of cell dying protein is a key participant in apoptosis depending on mitochondria and in illness development that includes the regulation of cell dying, reminiscent of tumorigenesis, diabetes, sepsis shock, and epilepsy. Nonetheless, the mechanisms underlying the immune responses to teleost BAD bacterial an infection and mitochondrial-dependent apoptosis stays unclear. So as to elucidate the mechanisms concerned, on this examine, a Ctenopharyngodon idella (grass carp) BAD gene named GcBAD1 was firstly cloned and characterised.

The outcomes indicated that the ORF (open studying body) of GcBAD1 was 438 bp in size, encoding a 145-amino acid putative protein of 16.66 kDa. This deduced amino acid sequence has a greater id than one other teleost species in keeping with a phylogenetic evaluation, and accommodates a Bcl2-BAD-1 area. In wholesome grass carp fish, the mRNA transcripts of GcBAD1 had been extensively current within the studied tissues, which could possibly be ranked as follows; spleen > mind > middle-kidney > head-kidney > liver > gills > intestines > coronary heart and muscle. As well as, throughout an infection by Aeromonas hydrophila and Staphylococcus aureus, the mRNA transcription and protein ranges expression of GcBAD1 within the head-kidney, spleen, and liver tissues of the fish had been considerably up-regulated.

Furthermore, when the C. idellus kidney cell line (CIK) cells had been incubated with Lipopolysaccharide (LPS) and lipoteichoic acid (LTA), the GcBAD1 expression transcripts had been additionally considerably up-regulated. Moreover, overexpression of GcBAD1 in CIK cells was in a position to activate apoptosis-related genes, together with these encoding p53, Cytochrome C (CytoC), caspase-3, and caspase-9.

Apart from, within the TUNEL assays, when pEGFP-BAD1 was over-expressed, the variety of crimson indicators related to apoptosis had been considerably elevated within the CIK cells contaminated with LPS or LTA at 12 h. This examine demonstrates that GcBAD1 has a big position within the mitochondrial apoptosis pathway of grass carp’s innate immunity. Our findings present new perception into the potential mechanisms of teleost antibacterial immunity.

Examine on results of miR-141-3p in proliferation, migration, invasion and apoptosis of colon most cancers cells by inhibiting Bcl2

Function: This examine aimed to research the connection between miR-141-3p and B lymphocyte-2 gene (Bcl2) gene and its organic conduct on colon most cancers cell line SW480.

Strategies: qRT-PCR was used to detect the expression degree of miR-141-3p in colon most cancers tissues and adjoining tissues, in addition to in colon most cancers cell line and regular human colonic epithelial cell line FHC. MTT assay, wound assay, and Transwell demonstrated the consequences of miR-141-3p on colon most cancers proliferation, migration and invasion. Targetscan7.1 predictive software program and twin luciferase reporter assays had been used to detect the focused regulation of miR-141-3p on the apoptosis-related gene Bcl2. MTT assay, wound assay, Transwell and circulation cytometry had been used to detect the impact of Bcl2 on miR-141-3p on colon most cancers proliferation, migration, invasion and apoptosis.

Outcomes: In contrast with adjoining tissues, the expression of miR-141-3p in colon most cancers tissues was considerably down-regulated. Colon most cancers sufferers with low expression of miR-141-3p had poorer prognosis. In contrast with regular colonic epithelial cells, miR-141-3p expression was considerably down-regulated in colon most cancers cell strains, and overexpression of miR-141-3p considerably attenuated the proliferation, migration and invasion of colon most cancers cells.

Knockdown of miR-141-3p considerably promoted the proliferation, migration and invasion of colon most cancers cells. miR-141-3p targets the unfavorable regulation of Bcl2. Knockdown of Bcl2 considerably attenuated the promotion of miR-141-3p inhibitor on proliferation, migration and invasion of colon most cancers cells and inhibition of apoptosis. Knockdown of Bcl2 considerably enhanced the inhibition impact of miR-141-3p inhibitor on proliferation, migration and invasion of colon most cancers cells.

Conclusions: In conclusion, miR-141-3p can inhibit the most cancers by regulating Bcl2, and miR-141-3p has the potential to grow to be a possible therapeutic goal for colon most cancers.

Key phrases: Bcl2; Colon most cancers; Malignant organic conduct; miR-141-3p.

Recombinant Human Hydroxymethylglutaryl-CoA lyase, GST, E.coli-50ug
QP6168-ec-50ug	EnQuireBio	50ug	EUR 315.6

Human Hydroxymethylglutaryl-CoA lyase, mitochondrial (HMGCL)
1-CSB-EP010563HU	Cusabio	EUR 456.00 EUR 256.80 EUR 1570.80 EUR 672.00 EUR 1047.60 EUR 314.40	100ug 10ug 1MG 200ug 500ug 50ug

Description: Recombinant Human Hydroxymethylglutaryl-CoA lyase, mitochondrial(HMGCL) expressed in E.coli

2-hydroxyacyl-CoA lyase 1 Antibody
39416-100ul	SAB	100ul	EUR 468

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
20-abx142080	Abbexa	EUR 444.00 EUR 727.20 EUR 360.00	100 ul 200 ul 50 ul

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
20-abx007133	Abbexa	EUR 493.20 EUR 710.40 EUR 218.40 EUR 376.80	100 ul 200 ul 20 ul 50 ul

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
20-abx002856	Abbexa	EUR 493.20 EUR 710.40	100 ul 200 ul

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
abx037986-100ug	Abbexa	100 ug	EUR 469.2

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
abx028671-400ul	Abbexa	400 ul	EUR 627.6

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
abx028671-80l	Abbexa	80 µl	EUR 343.2

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
abx030051-400ul	Abbexa	400 ul	EUR 627.6

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
abx030051-80l	Abbexa	80 µl	EUR 343.2

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
abx233928-100ug	Abbexa	100 ug	EUR 577.2

Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) Antibody
20-abx322761	Abbexa	EUR 526.80 EUR 393.60	100 ul 50 ul

anti-2 Hydroxy phytanoyl CoA lyase
YF-PA18196	Abfrontier	50 ul	EUR 435.6
Description: Mouse polyclonal to 2 Hydroxy phytanoyl CoA lyase

anti-2 Hydroxy phytanoyl CoA lyase
YF-PA18197	Abfrontier	50 ug	EUR 435.6
Description: Mouse polyclonal to 2 Hydroxy phytanoyl CoA lyase

Rhodobacter sphaeroides Modification methylase RsrI (rsrIM)
1-CSB-EP318583RLE	Cusabio	EUR 733.20 EUR 370.80 EUR 2192.40 EUR 1126.80 EUR 1461.60 EUR 476.40	100ug 10ug 1MG 200ug 500ug 50ug

Description: Recombinant Rhodobacter sphaeroides Modification methylase RsrI(rsrIM) expressed in E.coli

2-Hydroxyacyl-CoA Lyase 1 (HACL1) Antibody
20-abx110706	Abbexa	EUR 878.40 EUR 477.60	150 ul 50 ul

2-Hydroxyacyl-CoA Lyase 1 (HACL1) Antibody
abx145222-100ug	Abbexa	100 ug	EUR 469.2

2-Hydroxyacyl-CoA Lyase 1 (HACL1) Antibody
abx038305-100ug	Abbexa	100 ug	EUR 469.2

2-Hydroxyacyl-CoA Lyase 1 (HACL1) Antibody
abx233746-100ug	Abbexa	100 ug	EUR 610.8

2-Hydroxyacyl-CoA Lyase 1 (HACL1) Antibody
20-abx214192	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

2-Hydroxyacyl-CoA Lyase 1 (HACL1) Antibody
20-abx214272	Abbexa	EUR 493.20 EUR 360.00	100 ul 50 ul

Chicken Hydroxymethylglutaryl- CoA lyase, HMGCL ELISA KIT
ELI-27799c	Lifescience Market	96 Tests	EUR 1113.6

HMGCL 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Human Recombinant Protein
PROTP35914	BosterBio	Regular: 20ug	EUR 380.4
Description: HMGCL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 323 amino acids (28-325) and having a molecular mass of 34.2kDa.;HMGCL is fused to a 25 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Human Hydroxymethylglutaryl-CoA Lyase, Mitochondrial (HMGCL) ELISA Kit
abx387826-96tests	Abbexa	96 tests	EUR 1093.2

Hmgcl ELISA Kit\| Rat Hydroxymethylglutaryl-CoA lyase, mitochond
EF018825	Lifescience Market	96 Tests	EUR 826.8

Hmgcl ELISA Kit\| Mouse Hydroxymethylglutaryl-CoA lyase, mitocho
EF015212	Lifescience Market	96 Tests	EUR 826.8

Human 2-Hydroxyacyl-CoA Lyase 1 (HACL1) ELISA Kit
abx387730-96tests	Abbexa	96 tests	EUR 1093.2

Human 2- hydroxyacyl- CoA lyase 1, HACL1 ELISA KIT
ELI-27733h	Lifescience Market	96 Tests	EUR 988.8

Mouse 2- hydroxyacyl- CoA lyase 1, Hacl1 ELISA KIT
ELI-27598m	Lifescience Market	96 Tests	EUR 1038

Argininosuccinate Lyase (Recombinant)
20-abx073248	Abbexa	EUR 4101.60 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

HMGCL Human, 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Human Recombinant Protein, Sf9
PROTP35914-1	BosterBio	Regular: 10ug	EUR 380.4
Description: HMGCL Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 305 amino acids (28-325 a.a.) and having a molecular mass of 32.5kDa (Molecular size on SDS-PAGE will appear at approximately 28-40kDa). HMGCL is expressed with a 6 amino acid His tag at C-Terminus and purified by proprietary chromatographic techniques.

3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) Antibody
abx038037-100ug	Abbexa	100 ug	EUR 469.2

Rat 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase (HMGCL) ELISA Kit
abx391467-96tests	Abbexa	96 tests	EUR 1093.2

Mouse 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase (HMGCL) ELISA Kit
abx389578-96tests	Abbexa	96 tests	EUR 1093.2

3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) Antibody
20-abx310139	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Selenocysteine Lyase Recombinant Protein
92-018	ProSci	0.05 mg	EUR 852.9
Description: Selenocysteine Lyase belongs to the class-V pyridoxal-phosphate-dependent aminotransferase family. Selenocysteine Lyase exists as a homodimer in the cytosol. In the brain, Selenocysteine Lyase is as an enzyme that putatively salvages Sec and recycles the selenium for selenoprotein translation. Selenocysteine Lyase catalyzes the decomposition of L-selenocysteine to L-alanine and elemental selenium. Selenocysteine Lyase can be up-regulated In acute glomerulonephritis, it can also be regulated by JUN/AP-1.

Recombinant human Selenocysteine lyase
P2183	FN Test	100ug	Ask for price

Description: Recombinant protein for human Selenocysteine lyase

Cystathionine gamma-lyase, Recombinant
NATE-1144	Creative Enzymes	5mg	EUR 712.8

Cystathionine β-lyase, Recombinant
NATE-1146	Creative Enzymes	100mg	EUR 712.8

3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) Antibody (HRP)
20-abx310140	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) Antibody (FITC)
20-abx310141	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) Antibody (Biotin)
20-abx310142	Abbexa	EUR 493.20 EUR 2214.00 EUR 718.80 EUR 218.40 EUR 360.00	100 ug 1 mg 200 ug 20 ug 50 ug

Human 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) ELISA Kit
abx384525-96tests	Abbexa	96 tests	EUR 1093.2

Mouse 3-Hydroxymethyl-3-Methylglutaryl-CoA Lyase Like 1 (HMGCLL1) ELISA Kit
abx388460-96tests	Abbexa	96 tests	EUR 1093.2

Recombinant E.Coli N-Acetylneuraminate Lyase
7-03193	CHI Scientific	5µg	Ask for price

Recombinant E.Coli N-Acetylneuraminate Lyase
7-03194	CHI Scientific	20µg	Ask for price

Recombinant E.Coli N-Acetylneuraminate Lyase
7-03195	CHI Scientific	1mg	Ask for price

Cystathionine Gamma-Lyase Recombinant Protein
92-113	ProSci	0.05 mg	EUR 651.3
Description: Cystathionine Gamma-Lyase (CTH) belongs to the trans-sulfuration enzymes family. CTH exists as a homotetramer and interacts with CALM in a calcium-dependent manner. CTH breaks down cystathionine into cysteine, ammonia and 2-oxobutanoate. CTH catalyzes the last step in the trans-sulfuration pathway from methionine to cysteine and has broad substrate specificity. Defects in CTH will lead to cystathioninuria, which is an autosomal recessive phenotype characterized by abnormal accumulation of plasma cystathionine.

N-acetylneuraminate Pyruvate Lyase (Recombinant)
20-abx073214	Abbexa	EUR 4101.60 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

E.Coli N-Acetylneuraminate Lyase (Recombinant)
20-abx073216	Abbexa	EUR 4101.60 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

E.coli Deoxyribodipyrimidine photo-lyase (Recombinant)
20-abx073964	Abbexa	EUR 1930.80 EUR 393.60 EUR 276.00	100 ug 10 ug 2 µg

Recombinant human Cystathionine gamma-lyase
P1802	FN Test	100ug	Ask for price

Description: Recombinant protein for human Cystathionine gamma-lyase

Recombinant Cystathionine Gamma Lyase (CSE)
4-RPB538Hu01	Cloud-Clone	EUR 625.34 EUR 290.40 EUR 2015.04 EUR 751.68 EUR 1383.36 EUR 494.40 EUR 4857.60	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg

Description: Recombinant Human Cystathionine Gamma Lyase expressed in: E.coli

Recombinant Cystathionine Gamma Lyase (CSE)
4-RPB538Mu01	Cloud-Clone	EUR 633.95 EUR 292.80 EUR 2047.30 EUR 762.43 EUR 1404.86 EUR 499.20 EUR 4938.24	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg

Description: Recombinant Mouse Cystathionine Gamma Lyase expressed in: E.coli

Recombinant Cystathionine Gamma Lyase (CSE)
4-RPB538Ra01	Cloud-Clone	EUR 636.10 EUR 294.00 EUR 2055.36 EUR 765.12 EUR 1410.24 EUR 501.60 EUR 4958.40	100 ug 10ug 1 mg 200 ug 500 ug 50ug 5 mg

Description: Recombinant Rat Cystathionine Gamma Lyase expressed in: E.coli

Homocysteine ?,?-Lyase (rHCYase), Active, Recombinant
P1117-200	Biovision	each	EUR 510

Acyl-CoA oxidase, Recombinant
DIA-292	Creative Enzymes	1ku	EUR 324

Methylmalonyl CoA Epimerase (Recombinant)
20-abx073165	Abbexa	EUR 4101.60 EUR 393.60 EUR 276.00	1 mg 20 ug 5 ug

Acyl-CoA synthetase, recombinant
NATE-1682	Creative Enzymes	1ku	EUR 712.8

Recombinant Human Cystathionine γ-Lyase/CTH
CF60-10ug	Novoprotein	10ug	EUR 175.2
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human Cystathionine γ-Lyase/CTH
CF60-1mg	Novoprotein	1mg	EUR 2739.6
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human Cystathionine γ-Lyase/CTH
CF60-500ug	Novoprotein	500ug	EUR 1935.6
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human Cystathionine γ-Lyase/CTH
CF60-50ug	Novoprotein	50ug	EUR 406.8
Description: Supplied as a 0.2 μm filtered solution of 20mM PB,150mM NaCl,20% Glycerol,pH7.4.

Recombinant Human N-acetylneuraminate Pyruvate Lyase
7-03232	CHI Scientific	5µg	Ask for price

Recombinant Human N-acetylneuraminate Pyruvate Lyase
7-03233	CHI Scientific	20µg	Ask for price

Recombinant Human N-acetylneuraminate Pyruvate Lyase
7-03234	CHI Scientific	1mg	Ask for price

ATP citrate lyase recombinant monoclonal antibody
A5181	Bimake	100ul X 3	EUR 714

Description: A recombinant monoclonal antibody from rabbit against human ATP citrate lyase for WB,ELISA

Hyaluronate Lyase from Streptococcus pyogenes, recombinant
NATE-0346	Creative Enzymes	10mg	EUR 440.4

ADSL Adenylosuccinate Lyase Human Recombinant Protein
PROTP30566	BosterBio	Regular: 20ug	EUR 380.4
Description: ADSL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 520 amino acids (1-484) and having a molecular mass of 59kDa.;ADSL is fused to a 36 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

ASL Argininosuccinate Lyase Human Recombinant Protein
PROTP04424	BosterBio	Regular: 20ug	EUR 380.4
Description: ASL Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 484 amino acids (1-464) and having a molecular mass of 53.8kDa.;ASL is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

L-Methionine ?-Lyase, Pseudomonas putida recombinant
7848-100	Biovision	each	EUR 189.6

L-Methionine ?-Lyase, Pseudomonas putida recombinant
7848-500	Biovision	each	EUR 464.4

Recombinant Human Methylmalonyl CoA Epimerase
7-02737	CHI Scientific	5µg	Ask for price

Recombinant Human Methylmalonyl CoA Epimerase
7-02738	CHI Scientific	20µg	Ask for price

Recombinant Human Methylmalonyl CoA Epimerase
7-02739	CHI Scientific	1mg	Ask for price

Recombinant Human Acetyl-COA Acyltransferase
7-02362	CHI Scientific	5µg	Ask for price

Recombinant Human Acetyl-COA Acyltransferase
7-02363	CHI Scientific	20µg	Ask for price